Results for tag: "Seratrodast"

Seratrodast is a drug used to treat asthma, a chronic respiratory condition. It is a leukotriene receptor antagonist (LTRA) that works by blocking the action of leukotrienes, which are substances in the body that can cause asthma symptoms. Seratrodast is used to prevent asthma attacks and reduce the severity of symptoms. It is usually taken once a day, either as a tablet or an inhaler. Seratrodast is a relatively new drug, having been approved by the US Food and Drug Administration in 2019. It is available in both generic and brand-name forms. It is typically prescribed as a maintenance medication, meaning it is taken regularly to prevent asthma attacks. The Seratrodast market is a growing one, with more and more people being prescribed the drug each year. It is an important part of the overall asthma treatment landscape, providing an effective and safe option for those with the condition. Some companies in the Seratrodast market include GlaxoSmithKline, Merck, and Teva Pharmaceuticals. Show Less Read more